All articles in Alternative therapies for sleep apnea

ImThera Medical gets US FDA nod for pivotal study for obstructive sleep apnea device

Originally posted in PHARMABIZ.com San Diego, California
Wednesday, November 12, 2014, 14:00 Hrs  [IST]

ImThera Medical, a privately held global medical device company, announced that the US Food and Drug Administration (US FDA) has approved an investigational device exemption (IDE) for its THN3 Clinical Study. The THN3 Study will evaluate the safety and effectiveness of the aura6000 System for moderate to severe obstructive sleep apnea (OSA) in individuals who are unable to comply or unwilling to try PAP therapy or other OSA treatments. Data from this pivotal clinical study will be used to support a Pre-Market Approval (PMA) application for the aura6000 System.

“This is the most exciting innovation for the treatment of sleep apnea since CPAP,” said Michael Friedman, M.D., Professor of Otolaryngology and director of Chicago Sleep Center at Rush University Medical Center, Chicago IL and a study investigator. “I have had experience implanting the device during the earlier THN2 study.

Read More

Insomniacs Failing Drugs Suffer from Sleep Apnea

Researchers at the Sleep and Human Health Institute and Maimonides Sleep Arts & Sciences, Ltd investigated drug failure in 1210 chronic insomnia patients and found 91% of those who completed sleep studies actually suffered from previously undiagnosed sleep apnea, a critical factor likely to be aggravating their insomnia.

Albuquerque, N.M., /2014 — Millions of people suffer from chronic insomnia. Complaining of stress, racing thoughts, and other relevant nighttime symptoms, these individuals feel incapable of sleeping all through the night. As their frustrations mount, they try drugstore or online over-the counter (OTC) remedies and many consult physicians who prescribe even stronger medications. Yet, most of these sleep aids fail to alleviate insomnia symptoms, leaving them Sleepless in “Fill-in the City.” The Sleep and Human Health Institute conducted research identifying the cause of drug failure in chronic insomniacs and found overwhelming evidence indicating that most treatment-seeking insomnia patients suffer from unrecognized sleep apnea.

Read More

UPMC offers brand new sleep apnea treatment

 Posted: 10:29 a.m. Monday, June 16, 2014

PITTSBURGH —

About 12 million people are missing out on a good night’s sleep every day.  Sleep apnea can leave patients tired and out of options.  But now, there’s a brand new treatment that’s making history at UPMC.

Channel 11’s Katherine Amenta has an exclusive look at this game-changer.

“You wake up with a headache, every morning,” said Denise Hoover.

Hoover has started every day in pain for the past 20 years.  Sleep apnea has been robbing her of a deep sleep.

“Your tongue basically blocks your airway and you stop breathing,” said Hoover.  “You wake up gasping.”

It’s so bad, Denise hasn’t even had a dream in two decades.  Instead, she’s awake and sometimes wrestling with a CPAP mask.

She finally went to see Dr. Ryan Soose at UPMC Mercy.  He had a brand new solution that could end up making medical history.

Read More

New Positional Obstructive Sleep Apnea Therapy

By Jerrold Kram, MD, FCCP

A recently published study found that over 70% of those diagnosed obstructive sleep apnea and having an apnea-hypopnea index less than 60 are at least twice as severe when sleeping on their back as compared to other (non-supine) position.

This condition is referred to as “positional obstructive sleep apnea” (POSA). The most commonly recommended approach for treating POSA is to sew tennis balls into a night shirt. Several manufacturers (REMatee and Zzoma) developed commercial adaptations of the tennis-ball approach using cushions held in place by a waist belt or shoulder harness to restrict back-sleeping.

I recently read very promising study results using a novel position therapy device called the Night Shift. Worn on the back of the neck, Night Shift begins to vibrate when users start to sleep on their back and slowly increases in intensity until a position change occurs. For patients with POSA, 90% responded to Night Shift therapy and had a median apnea-hypopnea severity reduction of 79%!  

Read More

Pin It on Pinterest